Comment on "Treat-to-Target in Spondyloarthritis: Implications for Clinical Trial Designs"

被引：1

作者：

Wendling, Daniel ^{[1
,2
]}

Prati, Clement ^{[1
,2
]}

机构：

[1] CHRU Besancon, Univ Teaching Hosp, Dept Rheumatol, Besancon, France

[2] Univ Franche Comte, F-25030 Besancon, France

来源：

DRUGS | 2014年 / 74卷 / 14期

关键词：

ANKYLOSING-SPONDYLITIS; AXIAL SPONDYLOARTHRITIS; RECOMMENDATIONS; IMPROVEMENT; MANAGEMENT;

D O I：

10.1007/s40265-014-0288-3

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：1715 / 1716

页数：2

共 50 条

[1] Comment on “Treat-to-Target in Spondyloarthritis: Implications for Clinical Trial Designs”
Daniel Wendling
Clément Prati
Drugs, 2014, 74 : 1715 - 1716
[2] Treat-to-Target in Spondyloarthritis: Implications for Clinical Trial Designs
James Cheng-Chung Wei
Drugs, 2014, 74 : 1091 - 1096
[3] Treat-to-Target in Spondyloarthritis: Implications for Clinical Trial Designs
Wei, James Cheng-Chung
DRUGS, 2014, 74 (10) : 1091 - 1096
[4] Author's Reply to Wendling and Prati: "Treat-to-Target in Spondyloarthritis: Implications for Clinical Trial Designs"
Wei, James Cheng-Chung
DRUGS, 2014, 74 (14) : 1717 - 1718
[5] Author's Reply to Wendling and Prati: “Treat-to-Target in Spondyloarthritis: Implications for Clinical Trial Designs”
James Cheng-Chung Wei
Drugs, 2014, 74 : 1717 - 1718
[6] Diagnosis and Management of Late-Onset Spondyloarthritis: Implications of Treat-to-Target Recommendations
Éric Toussirot
Drugs & Aging, 2015, 32 : 515 - 524
[7] Diagnosis and Management of Late-Onset Spondyloarthritis: Implications of Treat-to-Target Recommendations
Toussirot, Eric
DRUGS & AGING, 2015, 32 (07) : 515 - 524
[8] SPONDYLOARTHRITIS Treat-to-target in spondyloarthritis-do we have a plan?
Maksymowych, Walter P.
NATURE REVIEWS RHEUMATOLOGY, 2013, 9 (09) : 507 - 508
[9] Treat-to-target in spondyloarthritis—do we have a plan?
Walter P. Maksymowych
Nature Reviews Rheumatology, 2013, 9 : 507 - 508
[10] Application of Treat-to-Target in Axial Spondyloarthritis in Daily Practice
Beckers, Esther
Boonen, Annelies
Webers, Casper
Ten Klooster, Peter
Vonkeman, Harald
Efde, Monique
van Tubergen, Astrid
ARTHRITIS & RHEUMATOLOGY, 2020, 72

← 1 2 3 4 5 →